Located in West Lebanon, New Hampshire, Novo Nordisk US Bio Production, Inc. (NNUSBPI), is a biopharmaceutical manufacturing facility that works to produce trusted products for people living with the rare bleeding disorder known as hemophilia.
Our key contribution is to discover and develop safe, innovative biological medicines and make them accessible to reach our goal of improving access to care. We work towards a future where all people living with hemophilia, with or without inhibitors, have the opportunity to live the life they desire.
Changing Hemophilia® represents Novo Nordisk’s commitment to the whole of the hemophilia community which links together all the company’s activities, from development of new treatments to support of community projects aimed at improving the lives of people with hemophilia.
In the Community
As 2015 marked the first full year Novo Nordisk has been part of the Lebanon, NH community, efforts to support the community are still in their initial stages. However, a major impact has already been made to support community activities that focus on promoting healthy living and outdoor activities with more to come.